The information on this site is exclusively intended for health care professionals.
All the information in this website is intended exclusively for Australian health care professionals and contains information pertaining to locally marketed products. Content regarding medication is informative. It is the responsibility of healthcare professionals to decide, on an individual basis, the most appropriate treatment to suit the needs of the patient.
You are leaving Progress in Mind Australia?
Lundbeck Therapeutic Areas Australia
Abilify Maintena®
(aripiprazole)
,
Reference: 1. Abilify Maintena Australian Product Information.
Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia.
This product is not listed on the PBS for the treatment of bipolar 1 disorder.
text
Body
Please review Approved Product Information before prescribing.
Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:
Abilify Maintena is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Abilify Maintena is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.
Access psychiatry and neurology resources any time you need them
Progress in Mind is exclusively for Australian healthcare professionals.
Please provide details to verify you are an Australian healthcare professional.
Your privacy is important. When you register, we may collect your personal information such as your name and contact details, as outlined at 'Lundbeck and Privacy’ on our Progress in Mind website.
,
